title: Therapy of acute myelogenous leukemia in adults.
authors.affiliation: Dept. of Hematology I, University, Rome, Italy.
authors.forename: M C
authors.initials: MC
authors.lastname: Petti
authors.forename: G
authors.initials: G
authors.lastname: Broccia
authors.forename: F
authors.initials: F
authors.lastname: Caronia
authors.forename: F
authors.initials: F
authors.lastname: Di Raimondo
authors.forename: G
authors.initials: G
authors.lastname: Fioritoni
authors.forename: S
authors.initials: S
authors.lastname: Ladogana
authors.forename: G
authors.initials: G
authors.lastname: Leone
authors.forename: V
authors.initials: V
authors.lastname: Liso
authors.forename: M
authors.initials: M
authors.lastname: Musso
authors.forename: A
authors.initials: A
authors.lastname: Neri
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007558:Italy / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015993:Life Tables; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D015996:Survival Rate; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D005047:Etoposide; D013866:Thioguanine; D003630:Daunorubicin